For: | Lin L, Wen ZB, Lin DJ, Dong JT, Jin J, Meng F. Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome. World J Clin Cases 2018; 6(4): 54-63 [PMID: 29670890 DOI: 10.12998/wjcc.v6.i4.54] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v6/i4/54.htm |
Number | Citing Articles |
1 |
Gulnar Mammadova, Ceren Ozkul, Selen Yilmaz Isikhan, Aylin Acikgoz, Bulent O. Yildiz. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population. European Journal of Clinical Investigation 2021; 51(4) doi: 10.1111/eci.13417
|
2 |
Toshihiko Kakiuchi, Yoshiki Tanaka, Hiroshi Ohno, Muneaki Matsuo, Kazuma Fujimoto. Helicobacter pyloriinfection-induced changes in the intestinal microbiota of 14-year-old or 15-year-old Japanese adolescents: a cross-sectional study. BMJ Open 2021; 11(7): e047941 doi: 10.1136/bmjopen-2020-047941
|
3 |
Song Yang, Ting Hu, He Liu, Ya-li Lv, Wen Zhang, Han Li, Lingling Xuan, Li-li Gong, Li-hong Liu. Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury. Biomedicine & Pharmacotherapy 2021; 138: 111441 doi: 10.1016/j.biopha.2021.111441
|